Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients (MuGard)

This study has been completed.
Information provided by (Responsible Party):
Access Pharmaceuticals, Inc. Identifier:
First received: January 25, 2011
Last updated: September 10, 2013
Last verified: September 2013